Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Altimmune Stock Is Perking Up Today

TheMotleyFool

0 0

Why Altimmune Stock Is Perking Up TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Shares of the developmental stage biotech Altimmune (NASDAQ: ALT) jumped by as much as 17.8% in pre-market trading Tuesday morning. The biotech's shares are perking up this morning in response to the pre-publication of an animal study for its intranasal COVID-19 vaccine candidate known as AdCOVID.

The manuscript is currently available on the pre-print biology server BioRxiv.org. Altimmune is developing AdCOVID in conjunction with the University of Alabama at Birmingham.

Image source: Getty Images.

Source Fool.com

Like: 0

ALT

Teilen